Isofol Medical AB (publ) (STO:ISOFOL)
Sweden · Delayed Price · Currency is SEK 0.7620
-0.0060 (-0.78%)
Sep 2, 2026, 5:29 PM CET
Isofol Medical AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 29.38 | 41.99 | 96.16 | 138.15 | 190.53 | 379.45 |
Short-Term Investments | 85.45 | 85 | - | - | - | - |
Cash & Short-Term Investments | 114.83 | 126.99 | 96.16 | 138.15 | 190.53 | 379.45 |
Cash Growth | 74.91% | 32.06% | -30.40% | -27.49% | -49.79% | 226.01% |
Accounts Receivable | - | - | - | - | 0.56 | 1.63 |
Other Receivables | 2.24 | 2.18 | 2.14 | 2.43 | 4.42 | 5.57 |
Receivables | 2.24 | 2.18 | 2.14 | 2.43 | 4.98 | 7.2 |
Prepaid Expenses | 1.49 | 0.23 | 0.12 | 0.01 | 0.39 | 0.51 |
Other Current Assets | - | - | - | - | 13.85 | 7.46 |
Total Current Assets | 118.56 | 129.4 | 98.42 | 140.59 | 209.75 | 394.61 |
Property, Plant & Equipment | - | - | - | 0 | 0.09 | 1.75 |
Long-Term Investments | - | - | - | - | 0.05 | - |
Other Long-Term Assets | - | - | - | - | - | 5.01 |
Total Assets | 118.56 | 129.4 | 98.42 | 140.6 | 209.89 | 401.36 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 3.81 | 2.73 | 2.03 | 1.99 | 7.87 | 17.74 |
Accrued Expenses | 19.11 | 16.88 | 16.21 | 14.31 | 40.88 | 54.51 |
Current Portion of Leases | - | - | - | - | - | 1.54 |
Other Current Liabilities | -0 | 1.3 | 1.58 | 1.95 | 1.79 | 9.23 |
Total Current Liabilities | 22.92 | 20.91 | 19.82 | 18.25 | 50.54 | 83.02 |
Long-Term Leases | - | - | - | - | - | 0.11 |
Other Long-Term Liabilities | 0.63 | 0.61 | 0.65 | 0.91 | 0.85 | - |
Total Liabilities | 23.55 | 21.53 | 20.47 | 19.16 | 51.39 | 83.13 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 9.81 | 8.61 | 4.95 | 4.95 | 4.95 | 4.95 |
Additional Paid-In Capital | 1,315 | 1,299 | 1,218 | 1,218 | 1,218 | 1,218 |
Retained Earnings | -1,230 | -1,199 | -1,145 | -1,102 | -1,065 | -904.32 |
Comprehensive Income & Other | -0 | - | 0 | 0 | - | 0 |
Shareholders' Equity | 95.01 | 107.87 | 77.95 | 121.43 | 158.5 | 318.23 |
Total Liabilities & Equity | 118.56 | 129.4 | 98.42 | 140.6 | 209.89 | 401.36 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | - | - | - | - | 1.65 |
Net Cash (Debt) | 114.83 | 126.99 | 96.16 | 138.15 | 190.53 | 377.8 |
Net Cash Growth | 74.91% | 32.06% | -30.40% | -27.49% | -49.57% | 233.52% |
Net Cash Per Share | 0.39 | 0.58 | 0.60 | 0.86 | 1.18 | 3.01 |
Filing Date Shares Outstanding | 320.49 | 281.11 | 161.52 | 161.52 | 161.52 | 161.52 |
Total Common Shares Outstanding | 320.49 | 281.11 | 161.52 | 161.52 | 161.52 | 161.52 |
Working Capital | 95.64 | 108.48 | 78.59 | 122.34 | 159.21 | 311.59 |
Book Value Per Share | 0.30 | 0.38 | 0.48 | 0.75 | 0.98 | 1.97 |
Tangible Book Value | 95.01 | 107.87 | 77.95 | 121.43 | 158.5 | 318.23 |
Tangible Book Value Per Share | 0.30 | 0.38 | 0.48 | 0.75 | 0.98 | 1.97 |
Machinery | - | 0.07 | 0.07 | 0.07 | 0.54 | 0.54 |